These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 11359810)

  • 1. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
    Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
    J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide.
    Nakagawa R; Inui T; Nagafune I; Tazunoki Y; Motoki K; Yamauchi A; Hirashima M; Habu Y; Nakashima H; Seki S
    J Immunol; 2004 Jun; 172(11):6550-7. PubMed ID: 15153469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
    Biburger M; Tiegs G
    J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice.
    Inui T; Nakashima H; Habu Y; Nakagawa R; Fukasawa M; Kinoshita M; Shinomiya N; Seki S
    J Hepatol; 2005 Oct; 43(4):670-8. PubMed ID: 15922476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 gene transfer potentiates the alpha-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma.
    Nishihori Y; Kato K; Tanaka M; Okamoto T; Hagiwara S; Araki N; Kogawa K; Kuribayashi K; Nakamura K; Niitsu Y
    Cancer Biol Ther; 2009 Sep; 8(18):1763-70. PubMed ID: 19901518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of NK1.1+ T cells in the rejection of lpr alphabetaT cells when bone marrow cells of lpr mice are transplanted into B6 mice.
    Tsukahara A; Kawamura H; Iiai T; Moroda T; Suzuki S; Tada T; Minagawa M; Musha N; Hatakeyama K; Abo T
    Microbiol Immunol; 1998; 42(6):447-56. PubMed ID: 9688079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.
    Yang JQ; Saxena V; Xu H; Van Kaer L; Wang CR; Singh RR
    J Immunol; 2003 Oct; 171(8):4439-46. PubMed ID: 14530371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.
    Trobonjaca Z; Kröger A; Stober D; Leithäuser F; Möller P; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2002 Apr; 168(8):3763-70. PubMed ID: 11937527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.